Early embryonic development is driven exclusively by maternal gene products deposited into the oocyte. Although critical in establishing early developmental programs, maternal gene functions have remained elusive due to a paucity of techniques for their systematic disruption and assessment. CRISPR-Cas13 systems have recently been employed to induce RNA degradation in yeast, plants and mammalian cell lines. However, no systematic study of the potential of Cas13 has been carried out in an animal system. Here, we show that CRISPR-Cas13d is an effective and precise system to deplete specific mRNA transcripts in zebrafish embryos. We demonstrate that both zygotically-expressed and maternally-provided transcripts are efficiently targeted, resulting in an 80% average decrease in transcript level and the recapitulation of well-known embryonic phenotypes. Moreover, we show that this system can be used in medaka, killifish and mouse embryos. Altogether our results demonstrate that CRISPR-Cas13d is an efficient knock-down platform to interrogate gene function in animal embryos.
CRISPR-Cas13d induces efficient mRNA knock-down in animal embryos
Gopal Kushawah,Joaquín Abugattas-Núñez Del Prado,J. Martínez-Morales,M. DeVore,J. R. Guelfo,Emry O. Brannan,Wei Wang,Timothy J Corbin,Andrea Moran,A. S. Alvarado,E. Málaga‐Trillo,Carter M. Takacs,A. Bazzini,M. Moreno-Mateos
Published 2020 in bioRxiv
ABSTRACT
PUBLICATION RECORD
- Publication year
2020
- Venue
bioRxiv
- Publication date
2020-01-14
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-69 of 69 references · Page 1 of 1